The endocannabinoid system and cancer: therapeutic implication.
about
Marijuana: current concepts(†)Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanismsTargeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilitiesEndocannabinoid system as a regulator of tumor cell malignancy - biological pathways and clinical significanceAnticancer mechanisms of cannabinoidsThe Cannabis Dilemma: A Review of Its Associated Risks and Clinical EfficacyThe hepatic cannabinoid 1 receptor as a modulator of hepatic energy state and food intakeCannabinoids as therapeutic agents in cancer: current status and future implicationsA lipid gate for the peripheral control of painThe molecular connections between the cannabinoid system and endometriosisKetoconazole inhibits the cellular uptake of anandamide via inhibition of FAAH at pharmacologically relevant concentrationsPotential upstream regulators of cannabinoid receptor 1 signaling in prostate cancer: a Bayesian network analysis of data from a tissue microarray.Cannabidiolic acid, a major cannabinoid in fiber-type cannabis, is an inhibitor of MDA-MB-231 breast cancer cell migration.Δ(9)-Tetrahydrocannabinol disrupts estrogen-signaling through up-regulation of estrogen receptor β (ERβ)Targeted zwitterionic near infrared fluorescent probe for improved imaging of type 2 cannabinoid receptors.The Therapeutic Aspects of the Endocannabinoid System (ECS) for Cancer and their Development: From Nature to Laboratory.Novel role of cannabinoid receptor 2 in inhibiting EGF/EGFR and IGF-I/IGF-IR pathways in breast cancer.Anandamide inhibits breast tumor-induced angiogenesisMarijuana: respiratory tract effects.The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids.TRPV1 mediates cellular uptake of anandamide and thus promotes endothelial cell proliferation and network-formation.Association between cannabinoid CB₁ receptor expression and Akt signalling in prostate cancer.Regulation of circulating endocannabinoids associated with cancer and metastases in mice and humans.Heteromerization of GPR55 and cannabinoid CB2 receptors modulates signallingThe influence of monoacylglycerol lipase inhibition upon the expression of epidermal growth factor receptor in human PC-3 prostate cancer cells.WIN 55,212-2, agonist of cannabinoid receptors, prevents amyloid β1-42 effects on astrocytes in primary culture.5-lipoxygenase mediates docosahexaenoyl ethanolamide and N-arachidonoyl-L-alanine-induced reactive oxygen species production and inhibition of proliferation of head and neck squamous cell carcinoma cellsCannabinoid receptor activation correlates with the proapoptotic action of the β2-adrenergic agonist (R,R')-4-methoxy-1-naphthylfenoterol in HepG2 hepatocarcinoma cellsLatest advances in novel cannabinoid CB(2) ligands for drug abuse and their therapeutic potential.Cannabidiol inhibits angiogenesis by multiple mechanisms.The potential relevance of the endocannabinoid, 2-arachidonoylglycerol, in diffuse large B-cell lymphoma.Towards the use of non-psychoactive cannabinoids for prostate cancerA Double Whammy: Targeting Both Fatty Acid Amide Hydrolase (FAAH) and Cyclooxygenase (COX) To Treat Pain and Inflammation.Modulating the endocannabinoid system in human health and disease--successes and failuresCritical appraisal of the potential use of cannabinoids in cancer management.Population-based case-control study of recreational drug use and testis cancer risk confirms an association between marijuana use and nonseminoma riskThe endocannabinoid system and sex steroid hormone-dependent cancers.Metabotyping human endometrioid endometrial adenocarcinoma reveals an implication of endocannabinoid metabolism.Association of marijuana smoking with oropharyngeal and oral tongue cancers: pooled analysis from the INHANCE consortium.Lead discovery, chemistry optimization, and biological evaluation studies of novel biamide derivatives as CB2 receptor inverse agonists and osteoclast inhibitors
P2860
Q21090461-CA727CD5-6ED5-4465-9329-9C55D6B2D4C5Q24622202-8B64A321-5982-41FC-BCC5-FFD0FA38662AQ24623282-DCDB5997-4B2F-4730-A063-21DC9CAFF3FBQ26739831-7DB34468-39D9-4A28-8BDB-DDF5E225A80AQ26750399-A746E129-FB67-471F-BEF9-F6A54F3F9B5FQ26779350-FCB4DF37-9620-4F0A-A489-B1591C060363Q26850858-923EDE49-8130-43EB-BC87-CF572E2C22E4Q26866298-34D7E1D2-424E-4452-BD37-09394F71A143Q26995053-9A1863B7-651E-4C2E-B2D3-BB89415514C5Q27005719-A38E4D4C-F65B-4352-BFB5-FDEB050A9BC3Q28539116-97DE9E2E-5733-4441-85B6-8A43BB3CA424Q30830112-4D519F9D-A177-4BF2-8B79-F61472680088Q33564023-ABEDDC02-BC59-43AD-A7E9-5C74F7BECED2Q33601161-0E487CC5-B2B3-4EF5-A5A4-840DFCDF2BCEQ33604098-0B78357A-D0AC-48A4-A5D7-ECAEEC15BCE0Q33623423-9025CD52-16B9-48C7-8FE8-270C21C73D44Q33728086-E1ACB907-3F2A-4730-AE8C-AD477D3E4EA4Q34074335-7701469D-0804-4416-9170-40475E7C88FDQ34347280-3EE77E72-A1D1-4AD0-BE93-CA6CB9D5F640Q34669534-795A591A-B231-45E6-953D-3F7D98D0B745Q34698703-8D96C141-4965-4F58-A92C-399962A96BAEQ34766747-3F256D73-2A3C-41EE-A313-B256E26C8B39Q34781231-23F46C7F-249A-449B-A730-EEAE358E5DB0Q34953430-39B23801-ABEF-4D34-9639-4EEDE4D76945Q35205032-BCF0CB0F-5C1A-4535-B3ED-C39E17CA9698Q35601542-3C2CF3F4-17AB-48CC-A519-40F5A1C6632EQ36076364-EC61E0F4-BD4F-4723-A52F-18E2219DA368Q36296849-0D6A9E55-EDBD-45A3-971C-47884375CDAFQ36408464-F88D08A8-215E-40C3-9CDB-194A10423F6AQ36419293-A54FD489-C095-40C7-943F-F19CE95AB9B4Q36575297-0564122E-45C2-43D4-A148-B54AA21E2B5DQ36603185-E52828E8-FBE4-41FC-ACE3-FDE8F6935A18Q36823364-08B57B26-D7E8-4803-8F5B-FD5276DC6F8DQ36933683-49394D3E-D434-4ECB-8A2E-0F87D6D3D5EFQ37164208-427F5572-F9DF-4385-A870-536904F52639Q37178515-C15EA930-BADB-4C1F-8EFD-1793C66CEE51Q37393042-C06E24F7-DEF1-4E67-9FFF-1412441C9DD5Q37588464-DA882A75-7F44-4ACB-B094-021C363647B6Q37625824-D55FFA82-E3DE-4B8C-A460-07273CD0B253Q37668664-57F49AEE-901E-4926-8167-9BCD03553F64
P2860
The endocannabinoid system and cancer: therapeutic implication.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The endocannabinoid system and cancer: therapeutic implication.
@ast
The endocannabinoid system and cancer: therapeutic implication.
@en
type
label
The endocannabinoid system and cancer: therapeutic implication.
@ast
The endocannabinoid system and cancer: therapeutic implication.
@en
prefLabel
The endocannabinoid system and cancer: therapeutic implication.
@ast
The endocannabinoid system and cancer: therapeutic implication.
@en
P2860
P1476
The endocannabinoid system and cancer: therapeutic implication.
@en
P2093
Andrea G Hohmann
Josée Guindon
P2860
P304
P356
10.1111/J.1476-5381.2011.01327.X
P407
P577
2011-08-01T00:00:00Z